Xarelto and Pradaxa offer alternatives to warfarin. While the two new drugs are more convenient to use and seem less likely to cause brain bleeding, only time will tell whether unforeseen side effects and risks crop up as more people use them. They are also more expensive than warfarin. People currently on warfarin who are thinking about switching and those with newly diagnosed atrial fibrillation who need to take a blood thinner should have a comprehensive conversation with their doctors about this important but very personal choice. If you do opt for one of the new drugs, pay attention to any future reports of adverse effects.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.